FDA Clinical Trials and Investigational Device Exemption (IDE)
25 Sep 2024
Clinical trials are important for developing new medical treatments and therapies. These trials ensure that new drugs, biologics, and medical devices are safe and effective before they reach patients. Through careful testing and evaluation, researchers gather important data that can lead to significant advancements in healthcare, ultimately improving patient outcomes and public health.
The Investigational Device Exemption (IDE) is a key part of this process. It allows new medical devices to be tested in clinical trials, helping researchers collect essential information on their safety and effectiveness. By doing so, FDA supports the development of innovative medical technologies while ensuring patient safety. This balance between encouraging innovation and maintaining high safety standards is essential for the progress of medical science and better patient care.
Learn about Combination Products’ Compliance Management in the USA and Quality System Regulations (QSR) and Good Manufacturing Practices (cGMP)
What are Clinical Trials?
Clinical trials are research studies where people volunteer to help answer specific health questions. When done carefully, they are the safest and quickest way to discover new treatments and improve health.
Clinical trials follow a detailed plan called a protocol. This protocol outlines:
- Who can take part in the study?
- The schedule for tests and procedures
- The drugs being tested
- The dosages of the drugs
- How long the study will last
- The goals of the study and what researchers aim to learn
Why are Clinical Trials Done?
Clinical trials are done for several important reasons:
- To find out if a new drug or device is safe and works well for people.
- To explore new ways to use existing treatments to make them more effective, easier to use, or to reduce side effects.
- To learn how to safely use a treatment in groups, it hasn’t been tested on before, like children.
Who Should Think About Joining Clinical Trials and Why?
All clinical trials have rules, called eligibility criteria, that determine who can take part in them. These criteria consider factors like age, gender, type and stage of disease, previous treatments, and other health conditions. These rules help make the study results more reliable and ensure researchers can find answers to their questions.
It’s also important to include a diverse group of participants because different people may respond differently to treatments. Thus, the FDA aims to ensure that clinical trials include people of various ages, races, ethnic groups, and genders.
Where Do Clinical Trials Take Place?
In the US, clinical trials can be funded and organized by various entities, such as pharmaceutical companies, federal agencies like the National Institutes of Health or the U.S. Department of Veterans Affairs, or individual doctors and healthcare providers. These sponsors choose where the trials take place, typically at universities, medical centers, clinics, hospitals, and other research sites funded by government or industry.
Are experiments in Clinical Trials Safe?
The FDA strives to safeguard clinical trial participants and make sure the public has access to trustworthy information when making decisions about participating in clinical studies. For clinical research, the federal government has rules and procedures in place to shield participants from unjustified risks. While every attempt is taken to minimize participant risks, some may remain inevitable because of ongoing research into the medical treatments used in the study.
Researchers are required by law to provide potential participants with accurate and comprehensive information about what to expect throughout the study. You will get an informed consent form outlining the study’s specifics, including any hazards, as well as your rights as a participant, prior to enrolling in that study. By signing it, you acknowledge that this is a research experiment and that you are free to end it whenever you choose. A step in the procedure that guarantees you are aware of the known dangers related to the study is the informed consent.
FDA’s Role in Approving New Drugs and Medical Treatments
The FDA ensures medical treatments are safe and effective for people. FDA staff meets with researchers and inspect clinical trial sites to safeguard patient rights and verify the quality and accuracy of the data collected.
What is a Placebo and Its Role in Clinical Trials?
A placebo is a substance like a pill, liquid, or powder that has no therapeutic effect—it’s often referred to as a “sugar pill.” In clinical trials, experimental drugs are frequently compared to placebos to assess how effective the treatment is.
What Happens to Drugs That Don’t Succeed in Clinical Trials?
Many drugs that are studied in preclinical (animal) research never advance to human testing or FDA review. Developers use what they learn from this research to refine and restart the development process.
Investigational Device Exemption (IDE)
An Investigational Device Exemption (IDE) permits the use of an investigational device in a clinical study to gather data on its safety and effectiveness. These studies typically aim to support a Pre-market Approval (PMA). Only a few 510(k) applications require clinical data. Investigational use also covers evaluating changes or new uses of devices already on the market. Any clinical evaluation of investigational devices, unless exempt, must have an approved IDE before the study starts.
When evaluating devices not yet cleared for market, they require:
- An institutional review board (IRB) approval of the investigational plan. For significant risk devices, FDA approval of an IDE is also necessary.
- Patient’s consent must be taken.
- Labels must show the device is for investigational use only.
- Studies must be monitored.
- Required records and reports must be maintained.
An approved IDE allows a device to be legally shipped for investigation with no need to meet all the usual requirements under the Food, Drug, and Cosmetic Act (FD&C Act) that apply to commercially distributed devices. Sponsors are not required to submit a PMA or 510(k), register their establishment, or list the device while it’s being investigated. IDE sponsors are also exempt from most Quality System (QS) Regulations, except for design controls (21 CFR 820.30).
Good Clinical Practices (GCP) for Clinical Trials
- 21 CFR 812, Investigational Device Exemptions: This covers the procedures for conducting clinical studies with medical devices, including the application process, responsibilities of sponsors and investigators, labeling requirements, and the management of records and reports.
- 21 CFR 50, Protection of Human Subjects: This outlines the requirements and basic components of informed consent.
- 21 CFR 56, Institutional Review Boards: This covers the procedures and responsibilities of institutional review boards (IRBs) that approve protocols for clinical investigations.
- 21 CFR 54, Financial Disclosure by Clinical Investigators: This covers the requirement of disclosing financial compensation to clinical investigators, which is important for the FDA’s assessment of the reliability of clinical data.
- 21 CFR 820 Subpart C, Design Controls of the Quality System Regulation: This outlines the requirement for procedures to control the design of the device to ensure it meets specified design requirements.
Are you worried about your FDA clinical trials?
At TS Q&E, we have regulatory consultants that have expertise in FDA clinical trials if you are a medical device or drug manufacturer looking forward to place their medical device in the US market, then we can help you comply with FDA’s requirements regarding clinical trials. To learn more about our consultancy services in clinical trials, visit us.
